Skip to main content

Transplant Diagnostics Market benefits from point-of-care testing rise with 6–8% CAGR by 2029

 


The global transplant diagnostics market is projected to grow at a CAGR of 6-8% over the next 5 years. The increasing prevalence of organ failure and growing awareness about organ transplantation are driving the demand for advanced transplant diagnostics. Technological advancements in molecular and genetic testing, alongside improving healthcare infrastructure in emerging regions, further fuel this market’s growth. Additionally, increased government funding for research on organ transplants and support for diagnostic innovations are also contributing to the expansion of the transplant diagnostics sector.

Transplant diagnostics involves an array of technologies, such as molecular assays, PCR, sequencing, and next-generation sequencing (NGS). These diagnostic tools are crucial for ensuring compatibility between donors and recipients, monitoring post-transplant rejection risks, and improving overall patient outcomes. Technologies like HLA typing and donor-specific antibody (DSA) testing play a pivotal role in reducing transplant rejection rates. Furthermore, real-time PCR and NGS technologies are enhancing transplant outcomes by providing rapid and accurate genetic matching and monitoring of transplant health.

🔗 Want deeper insights? Download the sample report:
https://meditechinsights.com/transplant-diagnostics-market/request-sample/

Growing number of organ transplant procedures is driving the market growth

The growing number of organ transplant procedures is a key driver in the expansion of the transplant diagnostics market. In 2023, the United States saw over 46,000 transplants, marking an 8.7% increase from the previous year. This growth is accompanied by a substantial rise in deceased donors, reaching more than 16,000, up by 9.6% compared to 2022. With more individuals in need of life-saving transplants, including kidneys, livers, hearts, and lungs, the demand for donor organs has intensified. The steady rise in organ donations and procedures not only highlights the increased willingness to donate but also underscores the pressing need for more advanced infrastructure to support this volume, which is reshaping the future of transplant care globally.

Growth Potential and Challenges for Transplant Diagnostics Market in Asia

There is high growth potential in the Asian transplant diagnostics market, though it faces some challenges. For instance, China has made significant strides in organ donation, with over 120100 major organs donated from 2015 to 2022. Additionally, more than 6.5 million people have registered as potential donors. This growing donor pool highlights the expanding market for transplant diagnostics, which supports organ compatibility testing and improves transplant success rates. However, there are challenges; organ donations per million people (PMP) remain below 4% in China, far behind developed countries at >45%. Additionally, a limited number of hospitals and high transplant costs constrain access, underscoring a need for further infrastructure and policy support.

Gain a competitive edge-request a sample report now! 
https://meditechinsights.com/transplant-diagnostics-market/request-sample/

Competitive Landscape Analysis

Key players in the global transplant diagnostics market include Thermo Fisher Scientific, Bio-Rad Laboratories, Illumina, Werfen (incl. Immucor, Omixon), Eurobio Scientific (incl. GenDx), and Roche; among others. Strategic acquisitions have remained central to the competitive strategies of these companies, aimed at strengthening their market positions and expanding their product offerings.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more